Neeraj KumarExecutive Director, General Management and Strategy Finance, Cardiovascular Metabolism and Neuroscience at NovartisSpeaker
Profile
Neeraj Kumar is a senior biopharma finance executive focused on enterprise capital allocation and long-term shareholder value creation. He leads U.S. finance across two major therapeutic portfolios, guiding capital deployment spanning lifecycle management, in-market performance, and business development. His experience spans venture-stage investing, pre-IPO and private equity valuation, corporate divestitures, and large-scale strategic transactions. Neeraj brings a full capital lifecycle perspective, bridging valuation rigor, strategic underwriting, and operating execution. He is a CFA charterholder and holds an MBA from Cornell University.
Agenda Sessions
Strategic Capital Deployment in Life Sciences: Investment Frameworks for Financial Leaders in 2026
, 4:30pmView Session
